Centella asiatica

DB14256Approved

Centella asiatica is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Mechanism
Curator reviewed
First approval
Canada, 1995
Also known as
Asiatic Pennywort Whole · Bacopa Monniera Whole Extract · Bacopa Whole · Brahmi Whole · Centella Asiatica Extract
Brand names
  • Madecassol

Resolves to

Compound
UNII7M867G6T1U
Clinical / RWD
RxNorm1807125
Targets
P08246ELANEP03956MMP1

What you can answer from here — as of August 04, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
90Drug interactionsStructured to mechanism, not free text
Sign in
18Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
57Marketed productsAcross 4 countries and 33 labellers
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Centella asiatica, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In